Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Keybanc Upgrades EMCOR Gr to Overweight, Announces $146 Price Target

Keybanc analyst Sean Eastman upgrades EMCOR Gr (NYSE:EME) from Sector Weight to Overweight and announces $146 price target.

byBenzinga Newsdesk

June 24, 2021

1 minute read

Keybanc analyst Sean Eastman upgrades EMCOR Gr (NYSE:EME) from Sector Weight to Overweight and announces $146 price target.

ComSovereign Holding Announces Pricing Of Public Offering Of 320K Shares Of Series A Cumulative Redeemable Perpetual Preferred Stock

By Benzinga Newsdesk

Today, 10:50 PM

COMSovereign Holding Corp. (NASDAQ:COMS) ("COMSovereign" or the "Company"), a U.S.-based developer of 4G LTE Advanced and 5G communication systems and solutions today announced the pricing of

COMS

Piper Sandler Maintains Neutral on Twitter, Lowers Price Target to $30

By Benzinga Newsdesk

Today, 10:50 PM

Piper Sandler analyst Thomas Champion maintains Twitter (NYSE:TWTR) with a Neutral and lowers the price target from $54.2 to $30.

TWTR

Morgan Stanley Maintains Overweight on Galapagos, Lowers Price Target to $77

By Benzinga Newsdesk

Today, 10:50 PM

Morgan Stanley maintains Galapagos (NASDAQ:GLPG) with a Overweight and lowers the price target from $118 to $77.

GLPG

Why TherapeuticsMD Shares Are Trading Higher Today

By Vandana Singh

Today, 10:50 PM

TherapeuticsMD Inc (NASDAQ:TXMD) shares are trading higher after FDA approved the supplemental application, including minor revisions to Annovera’s in vitro release testing…

TXMD

Keybanc Upgrades EMCOR Gr to Overweight, Announces $146 Price Target

Related Posts

ComSovereign Holding Announces Pricing Of Public Offering Of 320K Shares Of Series A Cumulative Redeemable Perpetual Preferred Stock

Piper Sandler Maintains Neutral on Twitter, Lowers Price Target to $30

Morgan Stanley Maintains Overweight on Galapagos, Lowers Price Target to $77

Why TherapeuticsMD Shares Are Trading Higher Today